XML 101 R73.htm IDEA: XBRL DOCUMENT v3.22.1

Other Financial Assets - Additional Information (Details) - EUR (€) € in Thousands	1 Months Ended	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of financial assets [line items]
Total amount of financial assets	€ 4,431	€ 4,431	€ 1,458	€ 1,727
Liquidity account, cash balance	513	€ 513	€ 688	€ 1,023
Number of shares recorded as deduction from equity (in shares)		137,012	88,929	18,132
Genoscience Pharma
Disclosure of financial assets [line items]
Subscription of new ordinary shares	€ 3,000

X

- Definition

Liquidity contract net.

+ References

No definition available.

+ Details

Name:	gnft_LiquidityContractNet
Namespace Prefix:	gnft_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Number of shares recorded as deduction from equity.

+ References

No definition available.

+ Details

Name:	gnft_NumberOfSharesRecordedAsDeductionFromEquity
Namespace Prefix:	gnft_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfFinancialAssetsLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The amount of financial assets that the entity does not separately disclose in the same statement or note. [Refer: Financial assets]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2021-01-01
-Paragraph 54
-Subparagraph d
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_d&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_OtherFinancialAssets
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

The cash outflow for the purchase of interests in investments accounted for using the equity method. [Refer: Investments accounted for using equity method]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2021-01-01
-Paragraph 16
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=gnft_GenosciencePharmaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: